Ikarian Capital, LLC Kura Oncology, Inc. Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $2.92 Million - $4.18 Million	-140,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $3.59 Million - $5.68 Million	-145,000 Reduced 50.88%	140,000 $3.96 Million
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $1.9 Million - $2.73 Million	65,600 Added 29.9%	285,000 $9.31 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $1.13 Million - $2.13 Million	69,400 Added 46.27%	219,400 $6.72 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $1.19 Million - $2.82 Million	150,000 New	150,000 $2.45 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.